Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: Seroconversion after prolonged follow-up

Kidney International

Volumn 87, Issue 6, 2015, Pages 1263-1264

  Van De Logt, Anne Els ^a   Hofstra, Julia M ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY;

ADULT; ANTIBODY DETECTION; CASE REPORT; FOLLOW UP; HUMAN; HUMAN TISSUE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LETTER; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; SEROCONVERSION; BLOOD; IMMUNOLOGY;

ANTIBODIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; SEROCONVERSION;

EID: 84930268972     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.34     Document Type: Article

References (2)

1. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
2. Fresquet M, Jowitt TA, Gummadova J et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol 2014 (e-pub ahead of print 6 October; doi:10.1681/ASN.2014050502).